Literature DB >> 17122075

Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone.

Liat Hershkovitz1, Felix Beuschlein, Steffen Klammer, Margalit Krup, Yacob Weinstein.   

Abstract

The enzyme 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD) is a progesterone-catabolizing enzyme that is highly expressed in mouse ovaries and adrenals. Although the functional significance of ovarian 20alpha-HSD for the induction of parturition has been defined, regulation and distribution of 20alpha-HSD in the adrenal gland has not been determined. We demonstrate that the expression of adrenal 20alpha-HSD is restricted to the X-zone, a transient zone between the adrenal cortex and the medulla of yet unknown function. Adrenal 20alpha-HSD activity in male mice peaks at 3 wk of age and disappears thereafter, whereas 20alpha-HSD enzyme activity is maintained in adrenals from nulliparous female animals. Testosterone treatment of female mice induces rapid involution of the X-zone that is associated with the disappearance of the 20alpha-HSD-positive cells. Conversely, reappearance of 20alpha-HSD expression and activity in male animals is evident after gonadectomy. Moreover, pregnancy, but not pseudopregnancy, is accompanied by X-zone regression and loss of 20alpha-HSD activity. Pregnancy-induced X-zone regression and -abolished 20alpha-HSD expression is partially restored in animals that were kept from nursing their pups. We found that in addition to its progesterone-reducing activity, 20alpha-HSD also functions as an 11-deoxycorticosterone-catabolizing enzyme. The unaltered growth kinetics of the X-zone in 20alpha-HSD knockout animals suggests that 20alpha-HSD is not required for the regulation of X-zone growth. However, 20alpha-HSD expression and enzymatic activity in all experimental paradigms is closely correlated with the presence of the X-zone. These findings provide the basis for 20alpha-HSD as a reliable marker of the murine X-zone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122075     DOI: 10.1210/en.2006-1100

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

Review 1.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

Review 2.  The cAMP pathway and the control of adrenocortical development and growth.

Authors:  Cyrille de Joussineau; Isabelle Sahut-Barnola; Isaac Levy; Emmanouil Saloustros; Pierre Val; Constantine A Stratakis; Antoine Martinez
Journal:  Mol Cell Endocrinol       Date:  2011-10-15       Impact factor: 4.102

3.  Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages.

Authors:  Peter King; Alex Paul; Ed Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

4.  The genetic basis of adrenal gland weight and structure in BXD recombinant inbred mice.

Authors:  Domenico L Di Curzio; Daniel Goldowitz
Journal:  Mamm Genome       Date:  2011-02-24       Impact factor: 2.957

5.  A Novel Population of Inner Cortical Cells in the Adrenal Gland That Displays Sexually Dimorphic Expression of Thyroid Hormone Receptor-β1.

Authors:  Chen-Che Jeff Huang; Cary Kraft; Nicole Moy; Lily Ng; Douglas Forrest
Journal:  Endocrinology       Date:  2015-03-16       Impact factor: 4.736

Review 6.  The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone.

Authors:  Chen-Che Huang; Yuan Kang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

7.  AgRP-Expressing Adrenal Chromaffin Cells Are Involved in the Sympathetic Response to Fasting.

Authors:  Rajesh Gupta; Yunbing Ma; Manqi Wang; Matthew D Whim
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

8.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis.

Authors:  Dai Chida; Shinichi Nakagawa; So Nagai; Hiroshi Sagara; Harumi Katsumata; Toshihiro Imaki; Harumi Suzuki; Fumiko Mitani; Tadashi Ogishima; Chikara Shimizu; Hayato Kotaki; Shigeru Kakuta; Katsuko Sudo; Takao Koike; Mitsumasa Kubo; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

9.  Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.

Authors:  Amélie Ménard; Nour Abou Nader; Adrien Levasseur; Guillaume St-Jean; Marie Le Gad- Le Roy; Derek Boerboom; Marie-Odile Benoit-Biancamano; Alexandre Boyer
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

10.  Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.

Authors:  Isabelle Sahut-Barnola; Cyrille de Joussineau; Pierre Val; Sarah Lambert-Langlais; Christelle Damon; Anne-Marie Lefrançois-Martinez; Jean-Christophe Pointud; Geoffroy Marceau; Vincent Sapin; Frédérique Tissier; Bruno Ragazzon; Jérôme Bertherat; Lawrence S Kirschner; Constantine A Stratakis; Antoine Martinez
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.